Summary
Influenza and pneumococcal vaccines have been available for decades and have repeatedly been shown to be efficacious in healthy adults. However, for both vaccines, efficacy in high risk populations and older individuals does not seem to be as great, leading to reluctance to use them as recommended. Recent observational studies in older individuals have confirmed and quantified the effectiveness of the 2 vaccines in situations of actual use. Economic data indicate that under realistic situations they are likely to reduce costs for healthcare systems. Societal benefits are now also established. While it may be useful to confirm the cost savings in additional systems of healthcare, the current emphasis should be to devise strategies to increase use of the vaccines.
Article PDF
Similar content being viewed by others
References
Serfling RE, Sherman IL, Housworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957–58, 1960, and 1963. Am J Epidemiol 1967; 86: 433–41
Fiebach N, Beckett W. Prevention of respiratory infections in adults: influenza and pneumococcal vaccines. Arch Intern Med 1994; 154: 2545–57
Perez-Tirse J, Gross PA. Review of cost-benefit analyses of influenza vaccine. PharmacoEconomics 1992; 2: 198–206
Butler JC, Brieman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826–31
Strassburg MA, Greenland S, Sorvillo FJ, et al. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4: 38–44
Coles FB, Balzano GJ, Morse DL. An outbreak of influenza A(H3N2) in a well immunized nursing home population. J Am Geriatr Soc 1992; 40: 589–92
Phair J, Kauffman CA, Bjornson A, et al. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med 1978; 92: 822–8
Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes: reduction in illnesses and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253: 1136–9
Office of Technology Assessment, US Congress. Cost effectiveness of influenza vaccination. Washington, DC: Government Printing Office, 1982
Meitl JF. Influenza immunization for Medicare eligibles: a demonstration of cost-effectiveness. Twenty-second Immunization Conference Proceedings. Atlanta (GA): United States Department of Health and Human Services, Public Health Services, 1988: 117–8
McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993; 153: 2105–11
Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296–307
Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24: 1240–8
Centers for Disease Control. Final results: Medicare influenza vaccine demonstration — selected states, 1988–1992. MMWR Morbid Mortal Wkly Rep 1993; 42: 601–4
Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccine in Manitoba. JAMA 1993; 270: 1956–61
Nichol KL, Margolis KL, Wuorenma H, et al. The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84
Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947–52
Mucher DM, Watson DA, Dominguez EA. Pneumococcal vaccination: work to date and future prospects. Am J Med Sci 1990; 300: 45–52
Heffron R. Pneumonia with special reference to pneumococcus lobar pneumonia. New York: The Commonwealth Fund, 1939: 446–78
Fedson DS, Wajda A, Nicol JP, et al. The old man’s friend [letter]. Lancet 1993; 342: 561
Austrian R, Douglas RM, Schiffman G, et al. Prevention of pneumonia by vaccination. Trans Assoc Am Phys 1976; 89: 184–94
Kerttula Y, Leinonen M, Koskela M, et al. The aetiology of pneumonia: application of bacterial serology and basic laboratory methods. J Infect 1987; 14: 21–30
Austrian R. A reassessment of pneumococcal vaccine. N Engl Med 1984; 310: 651–3
Clemens JD, Shapiro ED. Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials? Rev Infect Dis 1984; 6: 589–99
Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453–60
LaForce FM, Eickhoff TC. Pneumococcal vaccine: an emerging consensus. Ann Intern Med 1988; 108: 757–9
Forrester HL, Jahnigen DW, LaForce FM. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med 1987; 83: 425–30
Borgono JM, McLean AA, Vell PP, et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med 1978; 157: 148–54
Centers for Disease Control and Prevention. Pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep 1989; 38: 64–76
Sisk JF, Riegelman RK. Cost effectiveness of vaccination against pneumococcal pneumonia: an update. Ann Intern Med 1986; 104: 79–86
McBean AM, Babish JD, Prihoda R. The utilization of pneumococcal polysaccharide vaccine among elderly Medicare beneficiaries, 1985 through 1988. Arch Intern Med 1991; 151: 2009–16
Gable CB, Holzer SS, Engelhart L, et al. Pneumococcal vaccine: efficacy and associated cost savings. JAMA 1990; 264: 2910–5
DeStefano F, Goodman RT, Noble GR, et al. Simultaneous administration of influenza and pneumococcal vaccine. JAMA 1982; 247: 2551–4
Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77–83
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Monto, A.S., Terpenning, M.S. The Value of Influenza and Pneumococcal Vaccines in the Elderly. Drugs & Aging 8, 445–451 (1996). https://doi.org/10.2165/00002512-199608060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199608060-00006